{"id":45768,"date":"2025-11-04T21:44:18","date_gmt":"2025-11-04T13:44:18","guid":{"rendered":"https:\/\/flcube.com\/?p=45768"},"modified":"2025-11-04T21:44:19","modified_gmt":"2025-11-04T13:44:19","slug":"guangzhous-12%e2%80%91step-plan-to-accelerate-innovative-drug-and-device-adoption","status":"publish","type":"post","link":"https:\/\/flcube.com\/?p=45768","title":{"rendered":"Guangzhou\u2019s 12\u2011Step Plan to Accelerate Innovative Drug and Device Adoption"},"content":{"rendered":"\n<p>The Guangzhou Municipal Health Commission issued a comprehensive notice detailing twelve strategic measures aimed at <strong>streamlining the entry of innovative drugs and medical devices into hospitals, boosting clinical uptake, and refining the development ecosystem<\/strong>. The initiative covers procurement, clinical review, performance metrics, and research collaboration.<\/p>\n\n\n\n<h3 class=\"wp-block-heading\" id=\"h-1-strengthening-drug-procurement-and-access\">1. Strengthening Drug Procurement and Access<\/h3>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>Dual\u2011Channel Pharmacy System:<\/strong> Medical institutions must increase procurement of National Healthcare Security Administration (NHSA)\u2011negotiated drugs. Where a product is not yet on the hospital formulary, a dual\u2011channel pharmacy mechanism ensures prescriptions are issued \u201cas much as possible.\u201d<\/li>\n<\/ul>\n\n\n\n<h3 class=\"wp-block-heading\" id=\"h-2-enhancing-hospital-review-and-adoption\">2. Enhancing Hospital Review and Adoption<\/h3>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>Early PTC\/Device Committee Meetings:<\/strong> A Pharmacy &amp; Therapeutics Committee (PTC) or equivalent device committee must convene within one month of releasing the <strong>Guangzhou Innovative Drugs &amp; Medical Devices Catalog<\/strong>.<\/li>\n\n\n\n<li><strong>Minimum Annual Working Sessions:<\/strong> No fewer than four such committees\u2019 working meetings are required per year, providing a structured path for clinical evaluation.<\/li>\n<\/ul>\n\n\n\n<h3 class=\"wp-block-heading\" id=\"h-3-removing-usage-restrictions\">3. Removing Usage Restrictions<\/h3>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>License\u2011Free Stocking:<\/strong> Restrictions on the total number of drug varieties stocked by medical institutions are lifted.<\/li>\n\n\n\n<li><strong>Specification Relaxation:<\/strong> NHSA\u2011negotiated drugs are exempt from the \u201cone product, two specifications\u201d limitation.<\/li>\n<\/ul>\n\n\n\n<h3 class=\"wp-block-heading\" id=\"h-4-excluding-innovation-related-expenses-from-performance-metrics\">4. Excluding Innovation\u2011Related Expenses from Performance Metrics<\/h3>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>Performance\u2011Monitoring Exclusion:<\/strong> Costs related to innovative drugs and devices will <strong>not be reflected<\/strong> in public\u2011institution performance indicators such as average outpatient cost per visit or average inpatient drug cost.<\/li>\n\n\n\n<li><strong>Usage Limits Repealed:<\/strong> Institutions cannot curtail innovative products based on formulary size, drug\u2011to\u2011revenue ratio, consumable expenditure ratio, or monthly drug usage ceilings.<\/li>\n<\/ul>\n\n\n\n<h3 class=\"wp-block-heading\" id=\"h-5-promoting-collaborative-research-amp-development\">5. Promoting Collaborative Research &amp; Development<\/h3>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>\u201c1\u202f+\u202fN\u202f+\u202fX\u201d Regional Clinical\u2011Trial Alliance:<\/strong> Guangzhou will launch a regional alliance system with a focus on key specialties (oncology, respiratory diseases) to create a \u201c1\u202f+\u202fN\u202f+\u202fX\u201d partnership model.<\/li>\n\n\n\n<li><strong>Priority Support for Local Innovators:<\/strong> Firms developing innovative drugs and devices receive preferential support to join the alliance infrastructure.<\/li>\n<\/ul>\n\n\n\n<h3 class=\"wp-block-heading\" id=\"h-6-integrating-innovation-into-performance-evaluation\">6. Integrating Innovation into Performance Evaluation<\/h3>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>Performance\u2011Evaluation Re\u2011engineering:<\/strong> The commission will pilot the integration of the <strong>reasonable use of innovative products<\/strong>, cost\u2011control effectiveness, and patient\u2011benefit assessments into hospital and department performance evaluation frameworks.<\/li>\n<\/ul>\n\n\n\n<h2 class=\"wp-block-heading\" id=\"h-how-the-measures-translate-into-on-ground-change\">How the Measures Translate into On\u2011Ground Change<\/h2>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>Reduced Administrative Burden:<\/strong> Dual\u2011channel procurement eliminates bottlenecks, allowing physicians to prescribe breakthrough therapies without waiting for formulary approval.<\/li>\n\n\n\n<li><strong>Faster Clinical Adoption:<\/strong> Monthly committee meetings create a continuous dialogue between clinicians, pharmacists, and device specialists, accelerating evidence\u2011based uptake.<\/li>\n\n\n\n<li><strong>Rewarding Innovation:<\/strong> By removing innovative products from cost\u2011based performance metrics, hospitals no longer face financial penalties for adopting new therapies, encouraging risk\u2011taking in patient care.<\/li>\n\n\n\n<li><strong>Fostering Early\u2011Stage Development:<\/strong> The \u201c1\u202f+\u202fN\u202f+\u202fX\u201d alliance system positions Guangzhou as a regional hub for pivotal oncology and respiratory clinical trials, attracting both domestic and foreign innovators.<a href=\"https:\/\/flcube.com\/\">-Fineline Info &amp; Tech<\/a><\/li>\n<\/ul>\n","protected":false},"excerpt":{"rendered":"<p>The Guangzhou Municipal Health Commission issued a comprehensive notice detailing twelve strategic measures aimed at&#8230;<\/p>\n","protected":false},"author":1,"featured_media":45770,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"googlesitekit_rrm_CAownpewDA:productID":"","_jetpack_memberships_contains_paid_content":false,"footnotes":"","jetpack_publicize_message":"","jetpack_publicize_feature_enabled":true,"jetpack_social_post_already_shared":true,"jetpack_social_options":{"image_generator_settings":{"template":"highway","default_image_id":0,"font":"","enabled":false},"version":2}},"categories":[4],"tags":[],"class_list":["post-45768","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-policy-regulatory"],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v23.6 (Yoast SEO v27.5) - https:\/\/yoast.com\/product\/yoast-seo-premium-wordpress\/ -->\n<title>Guangzhou\u2019s 12\u2011Step Plan to Accelerate Innovative Drug and Device Adoption - Insight, China&#039;s Pharmaceutical Industry<\/title>\n<meta name=\"description\" content=\"The Guangzhou Municipal Health Commission issued a comprehensive notice detailing twelve strategic measures aimed at streamlining the entry of innovative drugs and medical devices into hospitals, boosting clinical uptake, and refining the development ecosystem. The initiative covers procurement, clinical review, performance metrics, and research collaboration.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/flcube.com\/?p=45768\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Guangzhou\u2019s 12\u2011Step Plan to Accelerate Innovative Drug and Device Adoption\" \/>\n<meta property=\"og:description\" content=\"The Guangzhou Municipal Health Commission issued a comprehensive notice detailing twelve strategic measures aimed at streamlining the entry of innovative drugs and medical devices into hospitals, boosting clinical uptake, and refining the development ecosystem. The initiative covers procurement, clinical review, performance metrics, and research collaboration.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/flcube.com\/?p=45768\" \/>\n<meta property=\"og:site_name\" content=\"Insight, China&#039;s Pharmaceutical Industry\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/profile.php?id=61566606313834\" \/>\n<meta property=\"article:published_time\" content=\"2025-11-04T13:44:18+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2025-11-04T13:44:19+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/flcube.com\/wp-content\/uploads\/2025\/11\/0409.webp\" \/>\n\t<meta property=\"og:image:width\" content=\"1080\" \/>\n\t<meta property=\"og:image:height\" content=\"608\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"author\" content=\"Fineline Cube\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:description\" content=\"Navigate the complexities of China\u2019s pharmaceutical industry with precision and clarity. FLCUBE delivers reliable data, news, and intelligence to broaden your horizons and sharpen your decision-making. Stay informed, stay ahead with FLCUBE.COM\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Fineline Cube\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=45768#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=45768\"},\"author\":{\"name\":\"Fineline Cube\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/person\\\/19ad11870d326204db8524d3c3c5e66a\"},\"headline\":\"Guangzhou\u2019s 12\u2011Step Plan to Accelerate Innovative Drug and Device Adoption\",\"datePublished\":\"2025-11-04T13:44:18+00:00\",\"dateModified\":\"2025-11-04T13:44:19+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=45768\"},\"wordCount\":450,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=45768#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2025\\\/11\\\/0409.webp\",\"articleSection\":[\"Policy \\\/ Regulatory\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\\\/\\\/flcube.com\\\/?p=45768#respond\"]}],\"copyrightYear\":\"2025\",\"copyrightHolder\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\"}},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=45768\",\"url\":\"https:\\\/\\\/flcube.com\\\/?p=45768\",\"name\":\"Guangzhou\u2019s 12\u2011Step Plan to Accelerate Innovative Drug and Device Adoption - Insight, China&#039;s Pharmaceutical Industry\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=45768#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=45768#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2025\\\/11\\\/0409.webp\",\"datePublished\":\"2025-11-04T13:44:18+00:00\",\"dateModified\":\"2025-11-04T13:44:19+00:00\",\"description\":\"The Guangzhou Municipal Health Commission issued a comprehensive notice detailing twelve strategic measures aimed at streamlining the entry of innovative drugs and medical devices into hospitals, boosting clinical uptake, and refining the development ecosystem. The initiative covers procurement, clinical review, performance metrics, and research collaboration.\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=45768#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/flcube.com\\\/?p=45768\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=45768#primaryimage\",\"url\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2025\\\/11\\\/0409.webp\",\"contentUrl\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2025\\\/11\\\/0409.webp\",\"width\":1080,\"height\":608,\"caption\":\"Guangzhou\u2019s 12\u2011Step Plan to Accelerate Innovative Drug and Device Adoption\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=45768#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/flcube.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Guangzhou\u2019s 12\u2011Step Plan to Accelerate Innovative Drug and Device Adoption\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#website\",\"url\":\"https:\\\/\\\/flcube.com\\\/\",\"name\":\"Insight, China's Pharmaceutical Industry\",\"description\":\"Fineline Insights, Pharma Clarity\",\"publisher\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/flcube.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\",\"name\":\"Fineline Infomation and Technology\",\"alternateName\":\"Fineline Info & Tech\",\"url\":\"https:\\\/\\\/flcube.com\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2024\\\/11\\\/Fineline-info-tech-scaled.jpg\",\"contentUrl\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2024\\\/11\\\/Fineline-info-tech-scaled.jpg\",\"width\":2560,\"height\":1894,\"caption\":\"Fineline Infomation and Technology\"},\"image\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.facebook.com\\\/profile.php?id=61566606313834\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/person\\\/19ad11870d326204db8524d3c3c5e66a\",\"name\":\"Fineline Cube\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g\",\"caption\":\"Fineline Cube\"},\"sameAs\":[\"https:\\\/\\\/flcube.com\"],\"url\":\"https:\\\/\\\/flcube.com\\\/?author=1\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Guangzhou\u2019s 12\u2011Step Plan to Accelerate Innovative Drug and Device Adoption - Insight, China&#039;s Pharmaceutical Industry","description":"The Guangzhou Municipal Health Commission issued a comprehensive notice detailing twelve strategic measures aimed at streamlining the entry of innovative drugs and medical devices into hospitals, boosting clinical uptake, and refining the development ecosystem. The initiative covers procurement, clinical review, performance metrics, and research collaboration.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/flcube.com\/?p=45768","og_locale":"en_US","og_type":"article","og_title":"Guangzhou\u2019s 12\u2011Step Plan to Accelerate Innovative Drug and Device Adoption","og_description":"The Guangzhou Municipal Health Commission issued a comprehensive notice detailing twelve strategic measures aimed at streamlining the entry of innovative drugs and medical devices into hospitals, boosting clinical uptake, and refining the development ecosystem. The initiative covers procurement, clinical review, performance metrics, and research collaboration.","og_url":"https:\/\/flcube.com\/?p=45768","og_site_name":"Insight, China&#039;s Pharmaceutical Industry","article_publisher":"https:\/\/www.facebook.com\/profile.php?id=61566606313834","article_published_time":"2025-11-04T13:44:18+00:00","article_modified_time":"2025-11-04T13:44:19+00:00","og_image":[{"width":1080,"height":608,"url":"https:\/\/flcube.com\/wp-content\/uploads\/2025\/11\/0409.webp","type":"image\/png"}],"author":"Fineline Cube","twitter_card":"summary_large_image","twitter_description":"Navigate the complexities of China\u2019s pharmaceutical industry with precision and clarity. FLCUBE delivers reliable data, news, and intelligence to broaden your horizons and sharpen your decision-making. Stay informed, stay ahead with FLCUBE.COM","twitter_misc":{"Written by":"Fineline Cube","Est. reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/flcube.com\/?p=45768#article","isPartOf":{"@id":"https:\/\/flcube.com\/?p=45768"},"author":{"name":"Fineline Cube","@id":"https:\/\/flcube.com\/#\/schema\/person\/19ad11870d326204db8524d3c3c5e66a"},"headline":"Guangzhou\u2019s 12\u2011Step Plan to Accelerate Innovative Drug and Device Adoption","datePublished":"2025-11-04T13:44:18+00:00","dateModified":"2025-11-04T13:44:19+00:00","mainEntityOfPage":{"@id":"https:\/\/flcube.com\/?p=45768"},"wordCount":450,"commentCount":0,"publisher":{"@id":"https:\/\/flcube.com\/#organization"},"image":{"@id":"https:\/\/flcube.com\/?p=45768#primaryimage"},"thumbnailUrl":"https:\/\/flcube.com\/wp-content\/uploads\/2025\/11\/0409.webp","articleSection":["Policy \/ Regulatory"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/flcube.com\/?p=45768#respond"]}],"copyrightYear":"2025","copyrightHolder":{"@id":"https:\/\/flcube.com\/#organization"}},{"@type":"WebPage","@id":"https:\/\/flcube.com\/?p=45768","url":"https:\/\/flcube.com\/?p=45768","name":"Guangzhou\u2019s 12\u2011Step Plan to Accelerate Innovative Drug and Device Adoption - Insight, China&#039;s Pharmaceutical Industry","isPartOf":{"@id":"https:\/\/flcube.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/flcube.com\/?p=45768#primaryimage"},"image":{"@id":"https:\/\/flcube.com\/?p=45768#primaryimage"},"thumbnailUrl":"https:\/\/flcube.com\/wp-content\/uploads\/2025\/11\/0409.webp","datePublished":"2025-11-04T13:44:18+00:00","dateModified":"2025-11-04T13:44:19+00:00","description":"The Guangzhou Municipal Health Commission issued a comprehensive notice detailing twelve strategic measures aimed at streamlining the entry of innovative drugs and medical devices into hospitals, boosting clinical uptake, and refining the development ecosystem. The initiative covers procurement, clinical review, performance metrics, and research collaboration.","breadcrumb":{"@id":"https:\/\/flcube.com\/?p=45768#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/flcube.com\/?p=45768"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/flcube.com\/?p=45768#primaryimage","url":"https:\/\/flcube.com\/wp-content\/uploads\/2025\/11\/0409.webp","contentUrl":"https:\/\/flcube.com\/wp-content\/uploads\/2025\/11\/0409.webp","width":1080,"height":608,"caption":"Guangzhou\u2019s 12\u2011Step Plan to Accelerate Innovative Drug and Device Adoption"},{"@type":"BreadcrumbList","@id":"https:\/\/flcube.com\/?p=45768#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/flcube.com\/"},{"@type":"ListItem","position":2,"name":"Guangzhou\u2019s 12\u2011Step Plan to Accelerate Innovative Drug and Device Adoption"}]},{"@type":"WebSite","@id":"https:\/\/flcube.com\/#website","url":"https:\/\/flcube.com\/","name":"Insight, China's Pharmaceutical Industry","description":"Fineline Insights, Pharma Clarity","publisher":{"@id":"https:\/\/flcube.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/flcube.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/flcube.com\/#organization","name":"Fineline Infomation and Technology","alternateName":"Fineline Info & Tech","url":"https:\/\/flcube.com\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/flcube.com\/#\/schema\/logo\/image\/","url":"https:\/\/flcube.com\/wp-content\/uploads\/2024\/11\/Fineline-info-tech-scaled.jpg","contentUrl":"https:\/\/flcube.com\/wp-content\/uploads\/2024\/11\/Fineline-info-tech-scaled.jpg","width":2560,"height":1894,"caption":"Fineline Infomation and Technology"},"image":{"@id":"https:\/\/flcube.com\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/profile.php?id=61566606313834"]},{"@type":"Person","@id":"https:\/\/flcube.com\/#\/schema\/person\/19ad11870d326204db8524d3c3c5e66a","name":"Fineline Cube","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g","caption":"Fineline Cube"},"sameAs":["https:\/\/flcube.com"],"url":"https:\/\/flcube.com\/?author=1"}]}},"jetpack_publicize_connections":[],"jetpack_featured_media_url":"https:\/\/flcube.com\/wp-content\/uploads\/2025\/11\/0409.webp","jetpack_sharing_enabled":true,"_links":{"self":[{"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts\/45768","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=45768"}],"version-history":[{"count":1,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts\/45768\/revisions"}],"predecessor-version":[{"id":45771,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts\/45768\/revisions\/45771"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/media\/45770"}],"wp:attachment":[{"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=45768"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=45768"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=45768"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}